Desde la fundación de nuestra estrategia de Private Equity en 1989, hemos invertido en más de 335 compañías en 40 países.
| Company | País | Sector | Description | Tipo de Negociación | Invest. date | |
|---|---|---|---|---|---|---|
 |
BioDuro
|
País China | Sector Healthcare | Description A leading global life sciences contract research and development organization | Tipo de Negociación Buyout | Invest. date Jan 2019 |
 |
Bharat Serums and Vaccines
|
País India | Sector Healthcare | Description A biopharmaceutical leader in women's healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets | Tipo de Negociación Buyout | Invest. date Feb 2020 |
 |
Cohance Lifesciences (formerly RA Chem Pharma Limited)
|
País India | Sector Healthcare | Description A vertically integrated API player, also engaged in manufacturing of pellets, B2B formulations and clinical studies | Tipo de Negociación Buyout | Invest. date Oct 2020 |
 |
GS Capsule
|
País Greater China | Sector Healthcare | Description A leading research, development and production company of hard capsules in China | Tipo de Negociación Buyout | Invest. date Dec 2021 |
 |
CARE Hospitals
|
País India | Sector Healthcare | Description Largest multi-specialty hospital chain in South and Central India | Tipo de Negociación Growth equity | Invest. date Mar 2012 |
 |
Thonburi Hospital
|
País Thailand | Sector Healthcare | Description Hospital providing general medical care, surgery, intensive care, cardiac care, x-ray and laboratory services | Tipo de Negociación Growth equity | Invest. date Jul 1994 |
 |
Suven Pharmaceuticals
|
País India | Sector Healthcare | Description A leader in the India pharma CDMO space | Tipo de Negociación Other | Invest. date Sep 2023 |
© 2002-2024 Advent International, L.P. All rights reserved
